BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 12, 2026
Breaking News: Read BioWorld's AACR 2026 coverage
Breaking News: Read BioWorld's AACR 2026 coverage
Breaking News: Best of BioWorld: Q1
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
GPR119 agonists for the treatment of obesity identified by iNovacia
Jan. 25, 2010
Lexicon's LX-4211 demonstrates improvements in phase II trial in type 2 diabetes
Jan. 22, 2010
Cobalamin oral insulin shows promise in preclinical trials
Jan. 22, 2010
Oramed completes patient enrollment in pivotal phase IIb trial of ORMD-0801
Jan. 22, 2010
Novo Nordisk obtains approval in Japan for Victoza for type 2 diabetes
Jan. 21, 2010
Acceleron adds two novel programs to development pipeline
Jan. 21, 2010
Xoma summarizes clinical development of its lead product XOMA-052
Jan. 21, 2010
Depomed plans for one additional phase III trial for menopausal hot flashes
Jan. 20, 2010
Date set for FDA Advisory Committee review of tesamorelin
Jan. 20, 2010
Glucobay OD approved in Japan for diabetes
Jan. 20, 2010
Previous
1
2
…
712
713
714
715
716
717
718
719
720
…
1792
1793
Next